Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Kioumi

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
British Journal of Haematology|October 31, 2002
Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3)Mario Cazzola, Laura Cremonesi, Maria Papaioannou, et al.
International Journal of Laboratory Hematology|July 11, 2022
Neonatal haemostatic parameters in correlation to gestational age and birth weightGeorgios Mitsiakos, Georgios N Katsaras, Abraham Pouliakis, et al.
World Journal of Gastroenterology|March 8, 2006
A case of successful management with splenectomy of intractable ascites due to congenital dyserythropoietic anemia type II-induced cirrhosisThemistoklis Vassiliadis, Vassilia Garipidou, Vassilios Perifanis, et al.
International Journal of Hematology|November 6, 2016
A retrospective study of azacitidine treatment in patients with intermediate-2 or high risk myelodysplastic syndromes in a real-world clinical setting in GreeceVasiliki Pappa, Achilles Anagnostopoulos, Eleni Bouronikou, et al.
Medicina (Kaunas, Lithuania)|August 27, 2021
TACI Mutations in Primary Antibody Deficiencies: A Nationwide Study in GreeceIoannis Kakkas, Gerasimina Tsinti, Fani Kalala, et al.
Annals of Hematology|May 15, 2018
Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survivalEirini Katodritou, Marie-Christine Kyrtsonis, Sosana Delimpasi, et al.
Annals of Hematology|June 27, 2018
Correction to: Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survivalEirini Katodritou, Marie-Christine Kyrtsonis, Sosana Delimpasi, et al.
Annals of Hematology|October 1, 2015
Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experienceEirini Katodritou, Evangelos Terpos, Efstathios Kastritis, et al.
Cancers|May 14, 2025
Lenalidomide Efficacy in Patients with MDS and Del-5q: Real-World Data from the Hellenic (Greek) National Myelodysplastic & Hypoplastic Syndromes Registry (EAKMYS)Argiris Symeonidis, Panagiotis Diamantopoulos, Athanasios Galanopoulos, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
British Journal of Haematology|October 31, 2002
Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3)Mario Cazzola, Laura Cremonesi, Maria Papaioannou, et al.
International Journal of Laboratory Hematology|July 11, 2022
Neonatal haemostatic parameters in correlation to gestational age and birth weightGeorgios Mitsiakos, Georgios N Katsaras, Abraham Pouliakis, et al.
World Journal of Gastroenterology|March 8, 2006
A case of successful management with splenectomy of intractable ascites due to congenital dyserythropoietic anemia type II-induced cirrhosisThemistoklis Vassiliadis, Vassilia Garipidou, Vassilios Perifanis, et al.
International Journal of Hematology|November 6, 2016
A retrospective study of azacitidine treatment in patients with intermediate-2 or high risk myelodysplastic syndromes in a real-world clinical setting in GreeceVasiliki Pappa, Achilles Anagnostopoulos, Eleni Bouronikou, et al.
Medicina (Kaunas, Lithuania)|August 27, 2021
TACI Mutations in Primary Antibody Deficiencies: A Nationwide Study in GreeceIoannis Kakkas, Gerasimina Tsinti, Fani Kalala, et al.
Annals of Hematology|May 15, 2018
Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survivalEirini Katodritou, Marie-Christine Kyrtsonis, Sosana Delimpasi, et al.
Annals of Hematology|June 27, 2018
Correction to: Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survivalEirini Katodritou, Marie-Christine Kyrtsonis, Sosana Delimpasi, et al.
Annals of Hematology|October 1, 2015
Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experienceEirini Katodritou, Evangelos Terpos, Efstathios Kastritis, et al.
Cancers|May 14, 2025
Lenalidomide Efficacy in Patients with MDS and Del-5q: Real-World Data from the Hellenic (Greek) National Myelodysplastic & Hypoplastic Syndromes Registry (EAKMYS)Argiris Symeonidis, Panagiotis Diamantopoulos, Athanasios Galanopoulos, et al.
Pageof 2